Daiichi Sankyo Belgium N.V.-S.A., a prominent subsidiary of the global pharmaceutical company Daiichi Sankyo, is headquartered in Belgium and operates extensively across Europe. Founded in 2005, the company has established itself in the pharmaceutical industry, focusing on innovative medicines in areas such as oncology, cardiovascular diseases, and vaccines. Daiichi Sankyo is renowned for its commitment to research and development, with a portfolio that includes unique therapeutic solutions designed to address unmet medical needs. The company’s advanced drug delivery systems and targeted therapies set it apart in a competitive market. With a strong market position, Daiichi Sankyo Belgium has achieved significant milestones, contributing to the advancement of healthcare in the region and beyond.
We don't have data for Daiichi Sankyo Belgium N.V.-S.A., but we can show you information about their parent organization instead.
View parent company